Form 4 for PTHS Pelthos Therapeutics Inc.
Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-10 · accession 0001753926-25-001884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-12 | 2025-07-02+ | PTHS | Pauls Matthew | Dir | M - OptEx | $0.00 | +10.6K | 8,493 | New | $0 |
| D | 2025-12-12 | 2025-12-10 | PTHS | Pauls Matthew | Dir | G - Gift | $0.00 | -9,542 | 1,074 | -90% | $0 |
| DM | 2025-12-12 | 2025-07-02+ | PTHS | Pauls Matthew | Dir | M - OptEx | $0.00 | -10.6K | 14.9K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-02 | M | A | 2,123 | $0.00 | 10,616 | D | — | — | (F1) As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units ("RSUs"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years. |
| 2 | Common | Common Stock | 2025-12-10 | G | D | 9,542 | $0.00 | 1,074 | D | — | — | (F2) On December 10, 2025, the Reporting Person transferred 9,542 shares of Common Stock to GP 2024 Trust, U/A Dated, 12/20/2024, for no consideration. The Reporting Person is not a trustee and does not retain investment or voting control over the shares. Following the gift, the Reporting Person disclaims beneficial ownership of the shares held by the Trust and reports beneficial ownership herein only to the extent of any pecuniary interest, if any. |
| 3 | Common | Common Stock | 2025-07-02 | M | A | 8,493 | $0.00 | 8,493 | D | — | — | (F1) As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units ("RSUs"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years. |
| 4 | Derivative | Restricted Stock Units | 2025-07-02 | M | D | 8,493 | $0.00 | 16,985 | D | — · — to — | 8,493 Common Stock | (F1) As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units ("RSUs"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years. (F3) Each RSU represents a contingent right to receive one share of issuer's Common Stock. |
| 5 | Derivative | Restricted Stock Units | 2025-10-02 | M | D | 2,123 | $0.00 | 14,862 | D | — · — to — | 2,123 Common Stock | (F1) As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units ("RSUs"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years. (F3) Each RSU represents a contingent right to receive one share of issuer's Common Stock. |